KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.1710
0.00 (0.00%)
At close: Nov 11, 2026, 4:00 PM EST
0.1711
+0.0001 (0.06%)
Pre-market: Nov 12, 2026, 5:23 AM EST

KALA BIO Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
31333196179
Market Cap Growth
-33.86%-60.80%74.89%-69.02%-23.21%-79.15%
Enterprise Value
-42221-15162
Last Close Price
0.1727.80347.00350.001907.503025.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-0.610.610.610.61-
PS Ratio
----15.647.05
PB Ratio
0.371.852.672.513.214.72
P/TBV Ratio
0.371.852.672.513.214.72

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
----13.105.50

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--2.624.842.264.77
Net Debt / Equity Ratio
-0.80-1.08-1.53-1.94-1.45-0.76
Net Debt / EBITDA Ratio
0.300.180.470.380.340.12
Net Debt / FCF Ratio
0.360.240.640.510.350.12
Asset Turnover
----0.030.06
Inventory Turnover
-----0.59
Quick Ratio
4.843.033.026.102.792.95
Current Ratio
6.883.813.116.343.353.32
Return on Equity (ROE)
-345.32%-279.18%-388.29%-318.75%-250.56%-244.19%
Return on Assets (ROA)
-65.43%-81.59%-45.36%-34.28%-44.95%-37.89%
Return on Capital Employed (ROCE)
-269.90%-606.20%-104.90%-82.20%-133.10%-107.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-761.35%-208.75%-116.81%-223.85%-73.65%-179.93%
FCF Yield
-601.07%-247.64%-89.75%-151.38%-130.18%-137.68%
Buyback Yield / Dilution
-6874.92%-114.65%-56.09%-59.94%-15.50%-25.67%
SEC Filings: 10-K · 10-Q